Cost: taking low-dose aspirin every day can relieve COPD!

March 7, 2019 / biool / - many Americans take low-dose aspirin every day to protect their hearts, but now a study shows that aspirin also seems to prevent chronic obstructive pulmonary disease In a study of patients with COPD, the researchers found that aspirin was related to the reduction of moderate deterioration of COPD, but not serious deterioration Aspirin can also reduce the attack of moderate to severe dyspnea Source: http://cn.bing.com "this study shows that adding aspirin to existing treatment regimens may improve the health of patients." Ashraf fawzy, a lung and critical care researcher at Johns Hopkins University, said, but said more research was needed to confirm Fawzy and his colleagues looked at nearly 1700 COPD patients, funded by NIH in the United States About 45% of patients reported that they regularly took low-dose aspirin (81 mg) at the beginning of the study The researchers found that over the next three years, patients who took aspirin had fewer attacks, better quality of life and fewer breathing difficulties COPD includes two chronic lung diseases: bronchitis and emphysema Smoking is the main cause, but long-term exposure to toxic dust and chemicals is also one of the causes Millions of Americans suffer from COPD, the third leading cause of lung disease-related deaths in the United States At present, there are treatments, but they cannot be cured Drugs usually include bronchodilators and anti-inflammatory drugs In more serious cases, patients need continuous oxygen inhalation Aspirin has been found to benefit heart attack and cardiovascular stroke patients, but its effect on COPD patients is unclear But since the study does not actually prove that aspirin causes a reduction in the number of attacks, aspirin is not recommended for COPD "It's hard to say COPD is a chronic disease, the treatment is very limited, we certainly welcome the new treatment, but at present, it is difficult to directly conclude that aspirin reduces the attack of the disease " Said Dr Alan mensch, senior vice president of medicine, Plainview and Syosset hospital This is because the study is called an observational study, and the researchers only compared different patients, but did not randomize them Fawzy said a randomized clinical trial was needed to determine whether aspirin could reduce the onset of the disease Mensch said one of the problems encountered when comparing COPD patients was that most of them had other diseases, such as cardiovascular disease But he also pointed out that some other studies have found that aspirin can prolong the life span of COPD patients and delay the progress of emphysema, so it may indeed be helpful So how does aspirin work? Aspirin is an anti-inflammatory drug, which may explain why aspirin can reduce the incidence of COPD Reference materials: Ashraf fawzy et al Aspirin use and revival probability in COPD Cost Doi: https://doi.org/10.1016/j.cost.2018.11.028